» Articles » PMID: 1713172

Alveolar Accumulation of Hyaluronan and Alveolar Cellular Response in Bleomycin-induced Alveolitis

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 1991 Apr 1
PMID 1713172
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Hyaluronan (HA) accumulating in the alveolar interstitial tissue of rats injured by a single intratracheal instillation of bleomycin has been visualized histologically and assayed. HA was present already by Day 1 after bleomycin treatment, increased to a maximum value on Days 3 and 7 and then declined. A time-dependent relationship between this early connective tissue response and the invasion of inflammatory cells in the alveolar tissue was apparent. The dominating invading cells by Day 1 were granulocytes showing positive staining for the monoclonal antibody OX-42 reflecting the C3b receptor. The numbers of macrophages expressing class II antigens started to increase on Day 1, reaching a maximum on Days 3-7 and then declined. Macrophages were the dominating OX-42+ cells by Day 7. The appearance of W3/13+ cells ("pan-T-lymphocytes") showed a similar pattern to that for the class II expressing macrophages. The number of cells expressing CD4 antigen increased until Day 3 and levelled off on Day 30 whilst the largest number of cells expressing CD8 antigen was seen on Day 30. Few cells expressing B-cell phenotype outside lymph nodules were identified. Alveolar lining epithelial cells, probably epithelial type II cells, expressed class II antigens by Days 3-14. The time-related accumulation of HA and the appearance of T-cells, macrophages and granulocytes expressing signs of activation suggests that these cells may be involved in the early connective tissue response of the lung injured by bleomycin.

Citing Articles

The Pattern of Elastic Fiber Breakdown in Bleomycin-Induced Pulmonary Fibrosis May Reflect Microarchitectural Changes.

Liu X, Ma S, Turino G, Cantor J Lung. 2016; 195(1):93-99.

PMID: 27761647 DOI: 10.1007/s00408-016-9956-2.


The Rise and Fall of Hyaluronan in Respiratory Diseases.

Lauer M, Dweik R, Garantziotis S, Aronica M Int J Cell Biol. 2015; 2015:712507.

PMID: 26448757 PMC: 4581576. DOI: 10.1155/2015/712507.


Hyaluronan as an immune regulator in human diseases.

Jiang D, Liang J, Noble P Physiol Rev. 2011; 91(1):221-64.

PMID: 21248167 PMC: 3051404. DOI: 10.1152/physrev.00052.2009.


Extracellular superoxide dismutase in pulmonary fibrosis.

Gao F, Kinnula V, Myllarniemi M, Oury T Antioxid Redox Signal. 2007; 10(2):343-54.

PMID: 17999630 PMC: 2290736. DOI: 10.1089/ars.2007.1908.


IL-9 protects against bleomycin-induced lung injury: involvement of prostaglandins.

Arras M, Louahed J, Heilier J, Delos M, Brombacher F, Renauld J Am J Pathol. 2005; 166(1):107-15.

PMID: 15632004 PMC: 1602305. DOI: 10.1016/S0002-9440(10)62236-5.